Ramis Catalbas

ORCID: 0000-0001-5817-9873
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Sepsis Diagnosis and Treatment
  • Inflammatory Biomarkers in Disease Prognosis
  • COVID-19 and healthcare impacts
  • Autoimmune and Inflammatory Disorders Research
  • Liver Disease Diagnosis and Treatment
  • Long-Term Effects of COVID-19

University of Health Science
2021

Memorial Ankara Hospital
2021

Royal College of Emergency Medicine
2021

Ankara Yıldırım Beyazıt University
2021

Aim: COVID-19 is a pandemic that causes high morbidity and mortality, especially in severe patients. In this study, we aimed to search explain the relationship between biochemical markers, which are more common, easily available applicable diagnose stage disease. Materials & methods: 609 patients were evaluated retrospectively. 11 parameters included analysis with severity of Results: Nearly, all have been study statistically valuable as predictive parameter for Areas under curve blood urea...

10.2217/fvl-2020-0319 article EN Future Virology 2021-05-01

Background: Pre-procedural anxiety is known to impact the quality of upper gastrointestinal endoscopy (esophagogastroduodenoscopy, EGD), particularly in non-sedated patients. Elevated levels can cause discomfort and reduce procedural success. Objectives: This study aimed evaluate effect pre-procedural anxiety, measured by State-Trait Anxiety Inventory (STAI), on EGD determine whether predict need for sedation. Design: was a prospective, cross-sectional conducted at tertiary care hospital....

10.1177/17562848251333025 article EN cc-by-nc Therapeutic Advances in Gastroenterology 2025-04-01

Coronavirus 2019 disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a pandemic infectious that causes morbidity and mortality. As result of high mortality rate among the COVID-19 patients, early detection stage effective interventions are very important in reducing Hence, it to differentiate nonsevere cases from each other. To date, there no proven diagnostic or prognostic parameters can be used this manner. Due expensive not easily accessible...

10.3906/sag-2008-6 article EN other-oa TURKISH JOURNAL OF MEDICAL SCIENCES 2021-03-17

In this study, we compare the predictive value of clinical scoring systems that are already in use patients with Coronavirus disease 2019 (COVID-19), including Brescia-COVID Respiratory Severity Scale (BCRSS), Quick SOFA (qSOFA), Sequential Organ Failure Assessment (SOFA), Multilobular infiltration, hypo-Lymphocytosis, Bacterial coinfection, Smoking history, hyper-Tension, and Age (MuLBSTA) system for reactive hemophagocytic syndrome (HScore), determining severity disease. Our aim study is...

10.1038/s41598-021-01181-x article EN cc-by Scientific Reports 2021-11-08

Abstract Introduction In this study, we compare the predictive value of clinical scoring systems that are already in use patients with COVID-19, including BCRSS, qSOFA, SOFA, MuLBSTA and HScore, for determining severity disease. Our aim study is to determine which system most useful disease guide clinicians. Materials Methods We classified into two groups according stage (severe non-severe) by using slightly modified adopted interim guidance World Health Organization. Severe cases were...

10.21203/rs.3.rs-362665/v1 preprint EN cc-by Research Square (Research Square) 2021-04-09
Coming Soon ...